Tal Teitz

Company: Ting Therapeutics

Job title: Associate Professor

Seminars:

Repurposing Small Molecule Therapeutics to Prevent Cisplatin-Induced & Noise-Induced Hearing Loss 3:00 pm

Preclinical studies with orally-delivered Dabrafenib for cisplatin-induced and noise-induced hearing loss Uncovering genetic mouse models for Debrafenib activity and the MAPK pathway Translation of repurposed FDA-approved small molecule drugs for prevention of hearing loss into clinical phase 1/2Read more

day: Conference Day 1